Radiotherapy Devices Global Market Report 2020-30


Posted November 10, 2020 by sonikashukla98

The global radiotherapy devices market is expected to decline from $5.75 billion in 2019 to $5.44 billion in 2020 at a compound annual growth rate (CAGR) of -5.35%. T
 
Bharat Book Bureau Provides the Trending Market Research Report on “Radiotherapy Devices Global Market Report 2020-30: Covid 19 Growth and Change”under Medical Devices Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

Radiotherapy Devices Global Market Report 2020-30: Covid 19 Growth and Change
Including: 1) By Product Type: External Beam Radiation Therapy Devices; Linear Accelerator Devices; Proton Therapy Devices
2) By Application: Skin Cancer; Breast Cancer; Prostate Cancer; Cervical Cancer; Lung Cancer; Others
3) By End Users: Hospitals; Ambulatory Surgical Centers; Oncological Treatment Centers
Covering: Varian Medical Systems; Elekta AB; Accuray, Inc.; C.R.Bard, Inc.; IBA Ion Beam Applications SA

Global Radiotherapy Devices Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global radiotherapy devices market.

This report focuses on radiotherapy devices market which is experiencing strong growth. The report gives a guide to the radiotherapy devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Request a free sample copy Radiotherapy Devices Market Report @
https://www.bharatbook.com/marketreports/sample/reports/2218887



Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the radiotherapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Radiotherapy Devices market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider radiotherapy devices market, and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
• The radiotherapy devices market section of the report gives context. It compares the radiotherapy devices market with other segments of the radiotherapy devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, radiotherapy devices indicators comparison.

Scope

Markets Covered: 1) By Product Type: External Beam Radiation Therapy Devices; Linear Accelerator Devices; Proton Therapy Devices
2) By Application: Skin Cancer; Breast Cancer; Prostate Cancer; Cervical Cancer; Lung Cancer; Others
3) By End Users: Hospitals; Ambulatory Surgical Centers; Oncological Treatment Centers

Companies Mentioned: Varian Medical Systems; Elekta AB; Accuray, Inc.; C.R.Bard, Inc.; IBA Ion Beam Applications SA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Major players in the radiotherapy devices market are Varian Medical Systems, Elekta AB, Accuray Inc., C.R.Bard Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay Inc. and GE Healthcare.

The radiotherapy devices market consists of sales of radiotherapy devices and related services by entities (organizations, sole traders and partnerships) that manufacture radiotherapy devices. Radiotherapy devices are used in cancer treatment by using high doses of radiation to kill cancer cells and shrink tumors. Only goods and services traded between entities or sold to end consumers are included.

The global radiotherapy devices market is expected to decline from $5.75 billion in 2019 to $5.44 billion in 2020 at a compound annual growth rate (CAGR) of -5.35%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $6.94 billion in 2023 at a CAGR of 8.47%.

The radiotherapy devices market covered in this report is segmented by product type into external beam radiation therapy devices; linear accelerator devices; proton therapy devices. It is segmented by application into skin cancer; breast cancer; prostate cancer; cervical cancer; lung cancer; others and by end users into hospitals; ambulatory surgical centers; oncological treatment centers.

Technological advancement is anticipated to drive the demand for the radiotherapy devices market. The advancement in technology is helping to develop low-cost, more effective and efficient, and user-friendly products with precise and improved radiation doses for increased performance in targeting tumors. The advancement from 2D radiotherapy devices to 3D with real-time imaging enabled high conformity of radiation to improve tumor control. For instance, in June 2020, Accuray Incorporated, a US-based radiation oncology company launched CyberKnife S7 System, a radiotherapy device combining advanced precision, real-time artificial intelligence, and speed motion tracking and synchronization treatment delivery for stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatments. Therefore, the launch of advanced devices is likely to propel the revenues for the radiotherapy devices market in the near future.

The high cost of radiotherapy is projected to limit the growth of the radiotherapy devices market as it uses complex machines and involves the services of skilled health care providers. The specific expense of radiation treatment relies upon the expense of medicinal services such as place of patient residence, type of radiation treatment, and the number of medicines required. For example, Proton Therapy is a high-cost therapy that is usually performed in metropolitical cities or at major academic centers. The treatment duration is eight weeks, which leads to huge expenditure on treatment and relocation. According to the report of National Cancer Institutes, approximately $150.8 billion were spent nationally for cancer care in 2018 in America. The high costs of cancer treatment are especially difficult to overcome among the poor or the uninsured or underinsured population. Therefore, the high cost associated with radiotherapy procedures is expected to restrain the growth of the market.

Artificial Intelligence (AI) is a leading trend in the radiotherapy devices market and is gaining significant popularity in the market. Incorporation of AI innovation in disease care is expected to improve the exactness and speed of analysis, help clinical dynamics, and lead to better results. For instance, in September 2019, Varian Medical Systems, a US-based manufacturer of radiation oncology medical devices, launched Ethos artificial intelligence radiotherapy device. The traditional treatment arranging process takes days to make an improved radiation treatment conveyance plan; however, the new AI advancements are helping to speed up this procedure. AI is also expected to include deep learning applications in treatment planning, clinical decision support, and automated image-guided adaptive radiation therapy and genomic/radio-biologic data mining, thus supporting the growth of the market.

In August 2020, Siemens Healthineers, a Germany-based medical technology company, announced its decision to acquire Varian Medical Systems Inc., for $16.4 billion. The deal is expected to expand Siemens Healthineer's definitive objective of overarching and comprehensive oncology portfolio, including Varian's linear accelerators, radiosurgery devices, and proton therapy suites to Siemens' imaging hardware, laboratory diagnostics, and hospital consulting services. Varian Medical Systems Inc. is a US-based radiation oncology treatments and software company.

Browse our full report with Table of Content : https://www.bharatbook.com/marketreports/radiotherapy-devices-global-market-report-2020-30-covid-19-growth-and-change/2218887

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Sonika
Phone 0222781077273
Business Address 808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703, INDIA
Country India
Categories Health
Tags radiotherapy devices market
Last Updated November 10, 2020